Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device

By Tacket C.O.   Roy M.J.   Widera G.   Swain W.F.   Broome S.   Edelman R.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2826-2829

Elsevier

Access to resources Recommend Favorite

Astounding influence of 'substance abuse', malnutrition and immune suppression on immune response to hepatitis B vaccine

By Arya S.C.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 879-879

Elsevier

Access to resources Recommend Favorite

Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India

By Murhekar M.V.   Murhekar K.M.   Arankalle V.A.   Sehgal S.C.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3431-3435

Elsevier

Access to resources Recommend Favorite

Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant

By Desombere I.   Van der Wielen M.   Van Damme P.   Stoffel M.   De Clercq N.   Goilav C.   Leroux-Roels G.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2597-2602

Elsevier

Access to resources Recommend Favorite

Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine

By McDermott A.B.   Cohen S.B.A.   Zuckerman J.N.   Madrigal J.A.  

Vaccine, Vol. 17, Iss. 4, 1999-02 ,pp. : 330-339

Elsevier

Access to resources Recommend Favorite